TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
3.965
-0.045 (-1.12%)
Mar 26, 2026, 9:53 AM EDT - Market open

TriSalus Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
20.448.5311.789.41250.21
Cash & Short-Term Investments
20.448.5311.789.41250.21
Cash Growth
139.75%-27.61%25.10%-96.24%-0.45%
Accounts Receivable
6.565.093.551.56-
Inventory
3.084.052.551.47-
Other Current Assets
2.173.012.994.770.33
Total Current Assets
32.2420.6720.8617.210.53
Net Property, Plant & Equipment
2.672.883.273.61-
Other Intangible Assets
---0.8-
Other Long-Term Assets
0.420.420.470.37-
Total Assets
35.3323.9724.622250.53
Accounts Payable
32.273.394.951.06
Accrued Expenses
8.17.3610.566.38-
Short-Term Debt
----0.54
Current Portion of Leases
0.170.220.350.37-
Other Current Liabilities
0.230.380.3920.66-
Total Current Liabilities
11.510.2314.6932.361.6
Long-Term Debt
33.4322.59---
Long-Term Leases
1.231.331.241.59-
Other Long-Term Liabilities
23.0415.7235.730.3715.65
Total Long-Term Liabilities
57.6939.6436.981.9615.65
Total Liabilities
69.1949.8751.6634.3217.25
Preferred Stock
---164.01-
Common Stock
000-0
Additional Paid-in Capital
296.72253.65222.4410.03-
Retained Earnings
-330.58-279.55-249.5-186.36-16.72
Total Common Shareholders' Equity
-33.86-25.89-27.07-176.33-16.72
Minority Interest
----250
Shareholders' Equity
-33.86-25.89-27.07-176.33233.28
Total Liabilities & Equity
35.3323.9724.622250.53
Total Debt
34.8224.141.61.960.54
Net Cash (Debt)
-14.39-15.6110.187.45249.66
Net Cash Growth
--36.65%-97.02%-0.67%
Net Cash Per Share
-0.38-0.621.0824.071139.50
Book Value
-33.86-25.89-27.07-176.33-16.72
Book Value Per Share
-0.89-1.02-2.88-569.52-76.30
Tangible Book Value
-33.86-25.89-27.07-177.13-16.72
Tangible Book Value Per Share
-0.89-1.02-2.88-572.12-76.30
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q